<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(11)</volume><submitter>Stammler R</submitter><journal>HemaSphere</journal><pagination>e70256</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12645798</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors.</pubmed_title><pmcid>PMC12645798</pmcid><pubmed_authors>Pascal L</pubmed_authors><pubmed_authors>Jachiet V</pubmed_authors><pubmed_authors>Abisror N</pubmed_authors><pubmed_authors>Merlot C</pubmed_authors><pubmed_authors>Goldwirt L</pubmed_authors><pubmed_authors>Ades L</pubmed_authors><pubmed_authors>Mirault T</pubmed_authors><pubmed_authors>Drevon L</pubmed_authors><pubmed_authors>Dalmas MC</pubmed_authors><pubmed_authors>Maria A</pubmed_authors><pubmed_authors>Rossignol J</pubmed_authors><pubmed_authors>Campagne J</pubmed_authors><pubmed_authors>Rieux-Laucat F</pubmed_authors><pubmed_authors>Lazaro E</pubmed_authors><pubmed_authors>Fenaux P</pubmed_authors><pubmed_authors>MINHEMON</pubmed_authors><pubmed_authors>Raffoux E</pubmed_authors><pubmed_authors>Mekinian A</pubmed_authors><pubmed_authors>Perrin F</pubmed_authors><pubmed_authors>Fain O</pubmed_authors><pubmed_authors>Terrier B</pubmed_authors><pubmed_authors>Merindol J</pubmed_authors><pubmed_authors>Zhao LP</pubmed_authors><pubmed_authors>Roos-Weil D</pubmed_authors><pubmed_authors>Chen P</pubmed_authors><pubmed_authors>Heiblig M</pubmed_authors><pubmed_authors>Thoreau B</pubmed_authors><pubmed_authors>Allain JS</pubmed_authors><pubmed_authors>Debeaupuis O</pubmed_authors><pubmed_authors>Stammler R</pubmed_authors><pubmed_authors>Ruyer-Thompson M</pubmed_authors><pubmed_authors>Lopez JG</pubmed_authors><pubmed_authors>Kosmider O</pubmed_authors><pubmed_authors>Mauhin W</pubmed_authors><pubmed_authors>Georgin-Lavialle S</pubmed_authors><pubmed_authors>Sebert M</pubmed_authors><pubmed_authors>De Voeght A</pubmed_authors><pubmed_authors>Rahme R</pubmed_authors><pubmed_authors>Cumin M</pubmed_authors><pubmed_authors>Hadjadj J</pubmed_authors><pubmed_authors>Zakine E</pubmed_authors><pubmed_authors>Duffau P</pubmed_authors><pubmed_authors>Gobert D</pubmed_authors><pubmed_authors>Hirsch P</pubmed_authors><pubmed_authors>Comont T</pubmed_authors><pubmed_authors>Couturier MA</pubmed_authors><pubmed_authors>Devloo C</pubmed_authors><pubmed_authors>Denis G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T18:59:30.353Z</modification><creation>2026-05-20T03:14:36.518Z</creation></dates><accession>S-EPMC12645798</accession><cross_references><pubmed>41306328</pubmed><doi>10.1002/hem3.70256</doi></cross_references></HashMap>